This compound is a pharmaceutical intermediate used in the manufacturing of the apalutamide metabolite. It is a carboxylic acid derivative containing a fluoro-substituted aromatic ring and a cyclobutane ring.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2170654-26-7
1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutane-1-carboxylic acid
Apalutamide active metabolite M19
Methyl 1-[3-fluoro-4-(methylcarbamoyl)anilino]cyclobutane-1-carboxylate
pharmaceutical intermediate for apalutamide
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Trilaciclib Impurity 3
Pharmaceutical impurity reference standard
Trilaciclib Impurity 35
Trilaciclib intermediate for pharmaceutical synthesis
4-((1-Cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide
pharmaceutical intermediate
1-[3-fluoro-4-(methylcarbamoyl)anilino]cyclobutane-1-carboxylic acid
FGOGELABKVPEAL-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)NC2(CCC2)C(=O)O)F